Equities

Allergy Therapeutics PLC

AGY:LSE

Allergy Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2.90
  • Today's Change0.025 / 0.87%
  • Shares traded10.69k
  • 1 Year change--
  • Beta1.9646
Data delayed at least 20 minutes, as of May 02 2024 10:05 BST.
More ▼

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Allergy Therapeutics plc share price to rise to 16.11 in the next year from the last price of 2.88.
High460.3%16.11
Med460.3%16.11
Low460.3%16.11

Earnings history & estimates

Allergy Therapeutics plc reported annual 2023 losses of -2.55 per share on Sep 27, 2023.
Average growth rate-38.43%
More ▼

Revenue history & estimates

Allergy Therapeutics plc had revenues for the full year 2023 of 60.95m. This was 16.24% below the prior year's results.
Average growth rate-4.01%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.